The content of this website is intended for United States audiences only.

Report an Adverse Event
/-/media/project/gileadclinicaltrial/header/arrow-right-img.svg

STATUS

Study of Novel Hepatitis B Virus (HBV) Combination Therapies in Adults with Chronic Hepatitis B (CHB)

OVERVIEW

A Phase 1b Open-Label, Proof of Concept Study to Evaluate the Safety and Efficacy of Novel Hepatitis B Virus (HBV) Combination Therapies in Chronic Hepatitis B (CHB) Subjects

PROTOCOL SUMMARY

The primary objective of this study is to evaluate the safety, tolerability, and efficacy of study treatment(s) in virally-suppressed participants with chronic hepatitis B (CHB) infection on oral nucleos(t)ide(s).

Participation Requirements

Calendar

Age

18 Years - 65 Years

Condition

Sex

ALL

Healthy Icon

Healthy Volunteers

No

Study Details

Medical Condition

Chronic Hepatitis B

Gender

N/A

Date

Study Type

INTERVENTIONAL

Study Phase

PHASE1b

Product